PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Cannabis » Bespoke Extracts Engages Daniel M. Slane to Spearhead New Business Development Initiatives in Key International Markets

Bespoke Extracts Engages Daniel M. Slane to Spearhead New Business Development Initiatives in Key International Markets

by PublicWire
April 26, 2019
in Cannabis
Reading Time: 2 mins read
0

SUNNY ISLES, Fla., Aug. 20, 2018 (GLOBE NEWSWIRE) — Bespoke Extracts, Inc. (OTCQB: BSPK), producer of high quality, great tasting, hemp-derived CBD extract products, today announced the engagement of Daniel M. Slane as a strategic advisor to the Company’s leadership. Bringing Bespoke Extracts over 40 years’ experience in global business, state and federal government and education, he is charged with spearheading and advising management on global expansion opportunities in key international markets, including Asia, Latin America and Europe.

Marc Yahr, Bespoke Extracts CEO, stated, “Given Dan’s depth and breadth of business-building experience on a worldwide basis, we expect that he will prove to be instrumental in helping our Company to expand our brand and optimize new business opportunities across the globe. We are delighted to welcome him to the team and look forward to working closely with him to help further distinguish Bespoke Extracts as one of the CBD’s industry’s leading providers of premium CBD products.”

A successful entrepreneur, Slane is the founder and Chairman of The Slane Company, which has developed 90 shopping centers and related commercial buildings in 12 states. The Company also owns and operates five other companies in tele-communications, waste, lumber and ethanol with offices and operations in the United States, United Kingdom and China.  In 2007, he was appointed to the U.S.-China Economic and Security Review Commission by the then Speaker of the House of Representatives, John Boehner; and in 2010, he was elected the Commission’s Chairman.  The China Commission is a Federal government agency created by Congress to monitor, investigate and submit to Congress an annual report on the national security implications, trade and economic relationship between the United States and China, and to provide recommendations to Congress for legislative and administrative action.

Over his impressive career, he has served on the boards of financial institutions and on a number of non-profit boards, including the Board of Trustees of Hiram College. In addition, in 2016, he was appointed to the Trump Transition team, charged with creating a national infrastructure plan for consideration by the Administration.  The former Chairman of the Board of Trustees of Ohio State University, Slane is also the former Chairman of University Hospital, a 1,000-bed hospital in Columbus; and the former Chairman of the Arthur G. James Cancer Hospital, one of the largest cancer research and treatment hospitals in the U.S.  He earned a B.S. in Business Administration in 1964 and his J.D. in 1967, both from Ohio State University. He served two years as a U.S. Army Captain in Military Intelligence before earning his M.A. in International Law in 1970 from the Europa Institute at the University of Amsterdam in the Netherlands.

Commenting on his engagement, Slane added, “I’m very pleased to be able to commit my skillset, expertise and influence to support Bespoke’s leadership team in their efforts to expand globally and hope that my contributions will play a significant role in the Company’s ultimate growth and success.”

About Bespoke Extracts, Inc.

Bespoke Extracts, Inc. was formed in early 2017 to introduce a proprietary line of premium quality, all-natural cannabidiol (CBD) products in the form of tinctures, balms, lotions and capsules for the nutraceutical and veterinary markets. Produced using pure, all natural, zero-THC phytocannabinoid-rich (“PCR”) hemp-derived CBD, our products are marketed as dietary supplements and distributed through our direct-to-consumers ecommerce store, found at www.bespokecbd.com.

Tags: Bespoke ExtractsBSPKCBD
Previous Post

Sugarmade Launches Industrial Hemp and CBD Initiative

Next Post

Renown HIV specialist Dr. Gary Blick Joins Immune Therapeutics Advisory Board

PublicWire

At PublicWire, we know the vast majority of all investors conduct their due diligence and get their news online in a variety of ways including email, social media, financial websites, text messages, RSS feeds and audio/video podcasts. PublicWire’s financial communications program is uniquely positioned to reach these investors throughout the U.S. and Canada as well as on a global scale.

Related Posts

Photo by GRAS GRÜN on Unsplash
Cannabis

Zenabis returned $1.9 million worth of pot to Sundial over bad quality and visible molds

August 22, 2019
0
Photo by Rick Proctor on Unsplash
Cannabis

Tilray to start exporting medicinal pot to Germany

August 21, 2019
0
Photo by Esteban Lopez on Unsplash
Cannabis

CannTrust stocks fell another 5% after weed distributor returned millions worth of pot

August 20, 2019
0
Photo by Roberto Valdivia on Unsplash
Cannabis

Cannabis stocks fell as possible recession brews

August 14, 2019
0
Cannabis

Aurora Cannabis hovers trade flat amid strong market

August 13, 2019
0
Photo by Get Budding on Unsplash
Cannabis

Health inspectors flagged CannTrust’s non-compliance again, sending stocks down by 26%

August 12, 2019
0
Next Post

Renown HIV specialist Dr. Gary Blick Joins Immune Therapeutics Advisory Board

Please login to join discussion

Subscribe To Our Newsletter

Loading
Ad
PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2022 publicwire.com

Navigate Site

  • About
  • Contact Us
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • Videos

© Copyright 2022 publicwire.com

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.